Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
暂无分享,去创建一个
Juan Manuel Ramos-Goñi | Oliver Rivero-Arias | Koonal K. Shah | N. Devlin | O. Rivero-Arias | K. Shah | Nancy J. Devlin | D. Mott | David J. Mott | J. Ramos-Goñi
[1] Mandy Ryan,et al. For better or worse? Investigating the validity of best–worst discrete choice experiments in health , 2019, Health economics.
[2] S. Paisley,et al. Are preferences over health states informed? , 2017, Health and Quality of Life Outcomes.
[3] M. Najafzadeh,et al. Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy , 2016, Expert review of pharmacoeconomics & outcomes research.
[4] Paul Kind,et al. Can adult weights be used to value child health states? Testing the influence of perspective in valuing EQ-5D-Y , 2015, Quality of Life Research.
[5] Mark Oppe,et al. International Valuation Protocol for the EQ-5D-Y-3L , 2020, PharmacoEconomics.
[6] N. Devlin,et al. DO ADULT AND ADOLESCENT PREFERENCES DIFFER? , 2019 .
[7] J. Bridges,et al. Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review , 2018, PharmacoEconomics.
[8] Mark Oppe,et al. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[9] Mark Oppe,et al. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] John M. Rose,et al. Applied Choice Analysis , 2015 .
[11] D. McFadden,et al. MIXED MNL MODELS FOR DISCRETE RESPONSE , 2000 .
[12] Stephane Hess,et al. Correlation and scale in mixed logit models , 2017 .
[13] L. Longworth,et al. An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[14] Afschin Gandjour,et al. Theoretical Foundation of Patient v. Population Preferences in Calculating QALYs , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.
[15] John Brazier,et al. Developing Adolescent-Specific Health State Values for Economic Evaluation , 2012, PharmacoEconomics.
[16] A. Stiggelbout,et al. Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[17] N. Devlin,et al. Methods for Analysing and Reporting EQ-5D Data , 2020 .
[18] J. Brazier,et al. Experience-based utility and own health state valuation for a health state classification system: why and how to do it , 2017, The European Journal of Health Economics.
[19] J. Ratcliffe,et al. Scoring the Child Health Utility 9D instrument: estimation of a Chinese child and adolescent-specific tariff , 2018, Quality of Life Research.
[20] P. Dolan,et al. An inquiry into the different perspectives that can be used when eliciting preferences in health. , 2003, Health economics.
[21] P. Kind,et al. Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale , 2020, The European Journal of Health Economics.
[22] K. Shah,et al. Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research , 2018, The Patient - Patient-Centered Outcomes Research.
[23] A. Brennan,et al. Should patients have a greater role in valuing health states? , 2005, Applied health economics and health policy.
[24] Michael Herdman,et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D , 2010, Quality of Life Research.
[25] Katherine Payne,et al. Accounting for Scale Heterogeneity in Healthcare-Related Discrete Choice Experiments when Comparing Stated Preferences: A Systematic Review , 2018, The Patient - Patient-Centered Outcomes Research.
[26] Deborah J Street,et al. One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation , 2018, PharmacoEconomics.
[27] Katherine Payne,et al. Scale Heterogeneity in Healthcare Discrete Choice Experiments: A Primer , 2018, The Patient - Patient-Centered Outcomes Research.
[28] A. Stiggelbout,et al. Health state utilities: a framework for studying the gap between the imagined and the real. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[29] J. González. A Guide to Measuring and Interpreting Attribute Importance , 2019, The Patient - Patient-Centered Outcomes Research.
[30] G. Bonsel,et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study , 2010, Quality of Life Research.
[31] A. Tsuchiya,et al. Re-Thinking 'The Different Perspectives That can be Used When Eliciting Preferences in Health'. , 2017, Health Economics.
[32] N. Devlin,et al. An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values , 2020, The European Journal of Health Economics.
[33] Denzil G. Fiebig,et al. The Generalized Multinomial Logit Model: Accounting for Scale and Coefficient Heterogeneity , 2010, Mark. Sci..
[34] W. Brouwer,et al. Patient and general public preferences for health states: A call to reconsider current guidelines. , 2016, Social Science & Medicine (1967).
[35] R. Norman,et al. Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling , 2020, PharmacoEconomics.
[36] K. Marsh,et al. Assessing Rationality in Discrete Choice Experiments in Health: An Investigation into the Use of Dominance Tests. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[37] Donna Rowen,et al. Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? , 2020, PharmacoEconomics.